RPG Life Sciences (NOT RATED): Annual investor conference takeaways
RPGL reported revenue growth, margin expansion and debt reduction in FY21 despite Covid-led disruptions in the acute portfolio
RPG Lifescience - A Turnaround Story
We believe that Rpg Life Sciences Ltd (RPGL IN) is at an inflection point with new products driving growth – both in Indian market (64%...
Profit from India's Rapidly Growing Biotechnology Industry
Now is a strategic time to focus on the upside potential of biotechnology companies in India, as India’s biotechnology industry is projected to...
India's Budgets: 2006-2015. Key Charts, and Key questions
In continuation of my work of detailed work on India Budget for last ten years, this piece through simple charts puts in perspective: 2014 Actual...
No more insights